Abstract
To study the evolution of drug resistance, we genetically and biochemically characterized Mycobacterium tuberculosis strains selected in vitro for ethambutol resistance. Mutations in decaprenylphosphoryl-β-D-arabinose (DPA) biosynthetic and utilization pathway genes Rv3806c, Rv3792, embB and embC accumulated to produce a wide range of ethambutol minimal inhibitory concentrations (MICs) that depended on mutation type and number. Rv3806c mutations increased DPA synthesis, causing MICs to double from 2 to 4 μg/ml in a wild-type background and to increase from 16 to 32 μg/ml in an embB codon 306 mutant background. Synonymous mutations in Rv3792 increased the expression of downstream embC, an ethambutol target, resulting in MICs of 8 μg/ml. Multistep selection was required for high-level resistance. Mutations in embC or very high embC expression were observed at the highest resistance level. In clinical isolates, Rv3806c mutations were associated with high-level resistance and had multiplicative effects with embB mutations on MICs. Ethambutol resistance is acquired through the acquisition of mutations that interact in complex ways to produce a range of MICs, from those falling below breakpoint values to ones representing high-level resistance.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zignol, M. et al. Global incidence of multidrug-resistant tuberculosis. J. Infect. Dis. 194, 479–485 (2006).
Sharma, S.K. & Mohan, A. Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control. Chest 130, 261–272 (2006).
Ramaswamy, S. & Musser, J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber. Lung Dis. 79, 3–29 (1998).
Riska, P.F., Jacobs, W.R. & Alland, D. Molecular determinants of drug resistance in tuberculosis. Int. J. Tuberc. Lung Dis. 4, S4–S10 (2000).
Telenti, A. et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat. Med. 3, 567–570 (1997).
Takiff, H.E. et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob. Agents Chemother. 38, 773–780 (1994).
Safi, H., Sayers, B., Hazbon, M.H. & Alland, D. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob. Agents Chemother. 52, 2027–2034 (2008).
Safi, H. et al. Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 54, 103–108 (2010).
Ramaswamy, S.V. et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 44, 326–336 (2000).
Plinke, C. et al. embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation. J. Antimicrob. Chemother. 65, 1359–1367 (2010).
Alderwick, L.J., Seidel, M., Sahm, H., Besra, G.S. & Eggeling, L. Identification of a novel arabinofuranosyltransferase (AftA) involved in cell wall arabinan biosynthesis in Mycobacterium tuberculosis. J. Biol. Chem. 281, 15653–15661 (2006).
Alderwick, L.J. et al. The C-terminal domain of the arabinosyltransferase Mycobacterium tuberculosis EmbC is a lectin-like carbohydrate binding module. PLoS Pathog. 7, e1001299 (2011).
Mikusová, K. et al. Decaprenylphosphoryl arabinofuranose, the donor of the D-arabinofuranosyl residues of mycobacterial arabinan, is formed via a two-step epimerization of decaprenylphosphoryl ribose. J. Bacteriol. 187, 8020–8025 (2005).
Mokrousov, I., Otten, T., Vyshnevskiy, B. & Narvskaya, O. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from northwestern Russia: implications for genotypic resistance testing. J. Clin. Microbiol. 40, 3810–3813 (2002).
Huang, H. et al. Identification and active expression of the Mycobacterium tuberculosis gene encoding 5-phospho-α-D-ribose-1-diphosphate: decaprenyl-phosphate 5-phosphoribosyltransferase, the first enzyme committed to decaprenylphosphoryl-D-arabinose synthesis. J. Biol. Chem. 280, 24539–24543 (2005).
Huang, H. et al. Identification of amino acids and domains required for catalytic activity of DPPR synthase, a cell wall biosynthetic enzyme of Mycobacterium tuberculosis. Microbiology 154, 736–743 (2008).
Vincent, V. et al. The TDR Tuberculosis Strain Bank: a resource for basic science, tool development and diagnostic services. Int. J. Tuberc. Lung Dis. 16, 24–31 (2012).
Starks, A.M., Gumusboga, A., Plikaytis, B.B., Shinnick, T.M. & Posey, J.E. Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 53, 1061–1066 (2009).
Comas, I. et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat. Genet. 44, 106–110 (2012).
Gagneux, S. et al. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312, 1944–1946 (2006).
Lee, R.E., Mikusova, K., Brennan, P.J. & Besra, G.S. Synthesis of the arabinose donor. β-D-arabinofuranosyl-1-monophosphoryldecaprenol, development of a basic arabinosyl-transferase assay, and identification of ethambutol as an arabinosyl transferase inhibitor. J. Am. Chem. Soc. 117, 11829–11832 (1995).
Goude, R., Amin, A.G., Chatterjee, D. & Parish, T. The Arabinosyltransferase EmbC is inhibited by ethambutol in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 53, 4138–4146 (2009).
Wolucka, B.A., McNeil, M.R., de Hoffmann, E., Chojnacki, T. & Brennan, P.J. Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J. Biol. Chem. 269, 23328–23335 (1994).
Wolucka, B.A. Biosynthesis of D-arabinose in mycobacteria—a novel bacterial pathway with implications for antimycobacterial therapy. FEBS J. 275, 2691–2711 (2008).
dos Reis, M., Wernisch, L. & Savva, R. Unexpected correlations between gene expression and codon usage bias from microarray data for the whole Escherichia coli K-12 genome. Nucleic Acids Res. 31, 6976–6985 (2003).
Higgs, P.G. & Ran, W. Coevolution of codon usage and tRNA genes leads to alternative stable states of biased codon usage. Mol. Biol. Evol. 25, 2279–2291 (2008).
Kudla, G., Murray, A.W., Tollervey, D. & Plotkin, J.B. Coding-sequence determinants of gene expression in Escherichia coli. Science 324, 255–258 (2009).
Goude, R., Amin, A.G., Chatterjee, D. & Parish, T. The critical role of embC in Mycobacterium tuberculosis. J. Bacteriol. 190, 4335–4341 (2008).
Escuyer, V.E. et al. The role of the embA and embB gene products in the biosynthesis of the terminal hexaarabinofuranosyl motif of Mycobacterium smegmatis arabinogalactan. J. Biol. Chem. 276, 48854–48862 (2001).
Ohno, H., Koga, H., Kohno, S., Tashiro, T. & Hara, K. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40, 1053–1056 (1996).
Hwang, H.-Y. et al. Characterization of rifampicin-resistant Mycobacterium tuberculosis in Taiwan. J. Med. Microbiol. 52, 239–245 (2003).
Kim, S.-Y. et al. Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. Diagn. Microbiol. Infect. Dis. 47, 497–502 (2003).
Safi, H. et al. IS6110 functions as a mobile, monocyte-activated promoter in Mycobacterium tuberculosis. Mol. Microbiol. 52, 999–1012 (2004).
van Embden, J.D. et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31, 406–409 (1993).
Colangeli, R. et al. Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-kike protein Lsr2 in M. tuberculosis. PLoS Pathog. 3, e87 (2007).
Supply, P. et al. Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis. Nat. Genet. 45, 172–179 (2013).
Scherman, M.S. et al. Polyprenylphosphate-pentoses in Mycobacteria are synthesized from 5-phosphoribose pyrophosphate. J. Biol. Chem. 271, 29652–29658 (1996).
Shui, G., Bendt, A.K., Pethe, K., Dick, T. & Wenk, M.R. Sensitive profiling of chemically diverse bioactive lipids. J. Lipid Res. 48, 1976–1984 (2007).
Acknowledgements
We thank S. Kuppasani for performing the direct Sanger sequencing. This work was supported in part by National Institute of Allergy and Infectious Diseases, US National Institutes of Health grants AI080653, AI065663 and AI037139 and by Pathogen Functional Genomics Resource Center contract N01-AI5447.
Author information
Authors and Affiliations
Contributions
H.S., S.L., A.A., M.J., M.M., S.N.P., D.C., R.F. and D.A. designed experiments. H.S., S.L., A.A. and M.J. performed experiments. H.S., A.A., M.H., M.M., S.N.P., D.C., R.F. and D.A. performed analysis of results. S.K., D.A. and H.S. performed statistical analysis. H.S., S.K., M.M., D.C., R.F. and D.A. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–5 and Supplementary Tables 1–3 (PDF 677 kb)
Rights and permissions
About this article
Cite this article
Safi, H., Lingaraju, S., Amin, A. et al. Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes. Nat Genet 45, 1190–1197 (2013). https://doi.org/10.1038/ng.2743
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2743
This article is cited by
-
Structural analysis of phosphoribosyltransferase-mediated cell wall precursor synthesis in Mycobacterium tuberculosis
Nature Microbiology (2024)
-
Antitubercular drugs: possible role of natural products acting as antituberculosis medication in overcoming drug resistance and drug-induced hepatotoxicity
Naunyn-Schmiedeberg's Archives of Pharmacology (2024)
-
Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach
Nature Communications (2024)
-
Heterologous production of the D-cycloserine intermediate O-acetyl-L-serine in a human type II pulmonary cell model
Scientific Reports (2023)
-
Whole-genome sequencing-based analyses of drug-resistant Mycobacterium tuberculosis from Taiwan
Scientific Reports (2023)